NCT04143711 2026-03-18Study of DF1001 in Patients With Advanced Solid TumorsDragonfly TherapeuticsPhase 1/2 Completed270 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00499291 2023-05-25Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT00470548 2018-01-10Abraxane and Alimta in Advanced Solid TumorsUniversity of California, DavisPhase 1/2 Terminated49 enrolled 10 charts
NCT00028535 2013-06-04Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed18 enrolled